The MLI Tissue Procurement and Cell Culture Core

Overview of Services

The Marsico Lung Institute (MLI) Tissue Procurement and Cell Culture Core is a critical resource for advancing cystic fibrosis (CF) research. It provides researchers with standardized primary airway epithelial cell cultures, which are indispensable for investigating CF pathophysiology and assessing the efficacy of novel therapeutic agents. These cultures frequently serve as a critical milestone test during the development of new CF treatments.

The Core pioneered the use of human CF lungs—obtained from transplantation—to generate its unparalleled cell bank. As a centralized facility, it supplies the scientific community with non-diseased "normal," CF, and various disease control cells, tissues, and fluids.

With over 42 years of operation, the Core has processed more than 8,600 human tissue specimens, producing an annual average of 93 billion viable primary human airway epithelial cells, underscoring its immense scale and impact on the field.

  • Custom Media
    • BEGM MEDIUM: Bronchial epithelial growth media for expansion of cells on plastic

    • ALI MEDIUM: Air-liquid interface media for differentiation of cells on porous supports

    • VALI MEDIUM: Vertex-ALI for differentiation of cells on porous supports (contains Ultroser G)-Please inquire about the availability of this product prior to ordering

  • Human Bronchial Epithelial Cells 
    • Non-Diseased "Normal" Donors: Cells from a donor history shows no prior chronic lung disease. 

    • Diseased Donors: Donor history shows prior chronic lung disease such as COPD, Asthma).

    • Cystic Fibrosis Donors: Homozygous severe CFTR mutation - (F508del/F508del).

    • Cystic Fibrosis Donors: Heterozygous F508del/second severe CFTR mutation - (F508del/Other).

    • Cystic Fibrosis Donors: Non F508del CFTR mutations - (Other CF/Other CF).

  • Other Human Lung Cells 

    • Non-Diseased Lung Microvascular Endothelial Cells: No history of prior chronic lung disease

    • Non-Diseased Lung Fibroblast Cells: No history of prior chronic lung disease

    • BMI Cell Line - Normal HBE Cell Line: UNCN1T, UNCN2T, UNCN3T - (Internal/External Academic Only)
    • BMI Cell Line - Cystic Fibrosis HBE Cell Line: UNCCF1T, UNCCF2T, UNCCF3T - (Internal/External Academic Only)
  • Well-Differentiated Human Cell Cultures
  • Non-diseased passage 2 or 3 human primary lung epithelial cells, cultured in ALI medium on collagen coated porous membranes
  • Passage 2 or passage 3 human primary lung epithelial cells, from donors with COPD or Asthma, cultured in ALI mediaum on collagen coated porous membranes
  • Age of maturity ~ 4 weeks in culture
  • Training
    • The MLI Tissue Core will provide training on basic Core techniques, protocols, and use of the EVOM Manual to measure TEER.
  • MTA Handling Fee
    • Cost of supplies used to generate shipments of MTA specimens requested
  • Labor
    • Cost for MLI Tissue Core staff to perform cell culture or other tasks requested by UNC CF investigators

All human cells test negative for mycoplasma, bacteria, yeast and fungi.

Leadership

Scott H. Randell, PhD | Core Director

Phillip W. Clapp, PhD / Core Co-Director

Leslie Fulcher / Core Program Manager  / 919-966-7055 / leslie_fulcher@med.unc.edu

 

 

Location and Hours of Operation

Location Hours

125 Mason Farm Rd

Marsico Hall #1109A

Chapel Hill, NC 27599

Monday - Friday

8 am - 5 pm

 

Links and Resources

  1. Tissue Procurement and Cell Culture Core

Contacts

Name Role Phone Email Location
Leslie Fulcher
Core Manager
 
919-966-7055
 
Leslie_Fulcher@med.unc.edu
 
1119 Marsico Hall
 
Allison Williams
Core Lead Technician
 
919-445-6481
 
Ablair05@email.unc.edu
 
1109A Marsico Hall
 
Phillip Clapp
Core Co-Director
 
919-445-6481
 
Phillip_Clapp@med.unc.edu
 
1113 Marsico Hall
 

ORDER HERE!


Search available services: View: by category alphabetically
Normal or Disease (COPD/Asthma) Large Airway Cells (4)
Media (5)
HBE Primary Cells Expanded using Conditionally Reprogrammed Cells (CRC) Methods (14)
Well-Differentiated Normal Cell Cultures (4)
Well-Differentiated Human Cystic Fibrosis Cell Cultures (4)
Well-Differentiated Normal or Disease LAE CRC Cell Cultures (2)
Well-Differentiated Human Cell Cultures and Commercial Media (8)
Well-Differentiated Normal and Disease SAE CRC Cell Cultures (4)
Well-Differentiated Non-CRC Cell Cultures from Donors with COPD or Asthma (4)
Other Human Lung Cells (5)
MTA Handling Rate (1)
Custom Cell Culture Work (1)
Training (2)
Tissue Distribution (1)